Ambulatory care databases for managed care organizations

被引:16
作者
Armstrong, EP [1 ]
Manuchehri, F [1 ]
机构
[1] UNIV ARIZONA,COLL PHARM,DEPT PHARM PRACTICE & SCI,TUCSON,AZ 85721
关键词
ambulatory care; clinical studies; computers; costs; data collection; databases; diseases; economics; errors; information; man aged care systems; methodology; models; outcomes; pharmacy; institutional;
D O I
10.1093/ajhp/54.17.1973
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The uses, advantages, and limitations of ambulatory care databases are discussed, and processes for extracting and using the data are described. Claims databases allow health systems, including managed care organizations, to generate descriptive statistics on patients, providers, and diseases; to conduct comprehensive cost and resource-use analyses; and to build economic models of diseases. The use of health care databases has several advantages over clinical trials, including lower data collection costs, shorter times for analysis, larger numbers of patients, and less inconvenience to patients and providers. These databases allow the effectiveness of a treatment, instead of its efficacy, to be assessed and drug-switching patterns within disease categories to be detected. This information can be used for determining the cost and outcome implications of new treatments and formulary changes, as well as for monitoring disease management programs. Limitations of health care databases include the omission of services not covered by health plans, the risk of coding errors, the absence of indicators of disease severity, and the lack of data that would assist with clinical outcome analysis. Medical and pharmacy claims data do not contain all the information contained in patients' medical-records. Despite their limitations, ambulatory care databases are useful for describing patient, provider, and disease characteristics. The databases are also useful for predicting and estimating the implications of a change in the formulary, measuring the effects of treatment guidelines, and monitoring disease management programs.
引用
收藏
页码:1973 / 1983
页数:11
相关论文
共 55 条
[1]  
[Anonymous], PHARMACOEPIDEMIOLOGY
[2]   Disease management programs [J].
Armstrong, EP ;
Langley, PC .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (01) :53-58
[3]  
BAZZOLI F, 1996, HLTH DATA MANAG, V4, P29
[4]   MEDICAID DATA AS A RESOURCE FOR EPIDEMIOLOGIC STUDIES - STRENGTHS AND LIMITATIONS [J].
BRIGHT, RA ;
AVORN, J ;
EVERITT, DE .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1989, 42 (10) :937-945
[5]  
CHRISCHILLES EA, 1992, DRUG INF J, V26, P219
[6]   Relational database for drug-use review of Tennessee Medicaid claims [J].
Chyka, PA ;
Holimon, TD ;
Tepedino, JT ;
Petersen, H .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (02) :164-166
[7]   From outcomes research to disease management: A guide for the perplexed [J].
Epstein, RS ;
Sherwood, LM .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (09) :832-837
[8]   INFORMATION-SYSTEMS FOR EVALUATING THE QUALITY OF PRESCRIBING [J].
FISH, CA ;
KIRKING, DM ;
MARTIN, JB .
ANNALS OF PHARMACOTHERAPY, 1992, 26 (03) :392-398
[9]   THE ACCURACY OF MEDICARES HOSPITAL CLAIMS DATA - PROGRESS HAS BEEN MADE, BUT PROBLEMS REMAIN [J].
FISHER, ES ;
WHALEY, FS ;
KRUSHAT, WM ;
MALENKA, DJ ;
FLEMING, C ;
BARON, JA ;
HSIA, DC .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1992, 82 (02) :243-248
[10]  
GABLE CB, 1992, J RES PHARM EC, V4, P53